The Drug Enforcement Administration has issued an Immediate Suspension Order to A+ Pharmacy in Chattanooga, Tenn., suspending the retail drugstore’s authority to handle controlled substances.
The action follows a joint investigation with the Tennessee Board of Pharmacy that identified violations of the Controlled Substances Act and compliance discrepancies, according to an April 6 news release from the agency.
The DEA issues Immediate Suspension Orders when it determines there is an imminent danger to public health or safety. A+ Pharmacy is prohibited from handling controlled substances while the suspension remains in effect.
DEA registrants have 30 days to request a hearing, though the suspension remains active during administrative proceedings.
The case is being investigated by the DEA’s Knoxville District Office and the Tennessee Board of Pharmacy.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
